Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 17382702)

1.

Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling.

Korkola JE, Kondagunta GV, Reuter VE, Motzer RJ, Chaganti RS.

J Urol. 2007 Apr;177(4):1264-8; discussion 1268.

PMID:
17382702
2.

Low expression of microphthalmia-associated transcription factor, a potential molecular target for interferon-alpha susceptibility, is associated with metastasis in renal cell carcinoma.

Shimazui T, Kojima T, Yoshikawa K, Ami Y, Oikawa T, Uchida K, Akaza H.

Cancer Sci. 2009 Sep;100(9):1714-8. doi: 10.1111/j.1349-7006.2009.01216.x. Epub 2009 May 12.

PMID:
19496784
3.

Prediction of in vitro response to interferon-alpha in renal cell carcinoma cell lines.

Shimazui T, Ami Y, Yoshikawa K, Uchida K, Kojima T, Oikawa T, Nakamura K, Honda N, Hinotsu S, Miyazaki J, Kunita N, Akaza H.

Cancer Sci. 2007 Apr;98(4):529-34. Epub 2007 Jan 31.

PMID:
17284252
4.
5.

Gene signatures of progression and metastasis in renal cell cancer.

Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA.

Clin Cancer Res. 2005 Aug 15;11(16):5730-9.

6.

STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.

Ito N, Eto M, Nakamura E, Takahashi A, Tsukamoto T, Toma H, Nakazawa H, Hirao Y, Uemura H, Kagawa S, Kanayama H, Nose Y, Kinukawa N, Nakamura T, Jinnai N, Seki T, Takamatsu M, Masui Y, Naito S, Ogawa O.

J Clin Oncol. 2007 Jul 1;25(19):2785-91.

7.

Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma.

Tan X, Zhai Y, Chang W, Hou J, He S, Lin L, Yu Y, Xu D, Xiao J, Ma L, Wang G, Cao T, Cao G.

Int J Cancer. 2008 Sep 1;123(5):1080-8. doi: 10.1002/ijc.23637.

PMID:
18546293
8.

Transcriptional program associated with IFN-alpha response of renal cell carcinoma.

Banerjee D, Chadalavada RS, Bourdon V, Korkola JE, Motzer RJ, Chaganti RS.

J Interferon Cytokine Res. 2006 Mar;26(3):156-70.

PMID:
16542138
9.

[Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma].

Luu VD, Fischer B, von Teichman A, Boysen G, Mertz K, Zimmermann P, Moch H, Schraml P.

Pathologe. 2008 Nov;29 Suppl 2:303-7. doi: 10.1007/s00292-008-1031-1. German.

PMID:
18751980
10.
11.

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1363-9. doi: 10.1007/s00432-008-0412-4. Epub 2008 May 16.

PMID:
18483744
12.

Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.

Lovisolo JA, Casati B, Clerici L, Marafante E, Bono AV, Celato N, Salvadore M.

BJU Int. 2006 Jul;98(1):205-16.

PMID:
16831170
13.

Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma.

Diegmann J, Tomiuk S, Sanjmyatav J, Junker K, Hindermann W, von Eggeling F.

Int J Mol Med. 2006 Sep;18(3):395-403.

PMID:
16865223
14.

Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.

Miyake H, Sakai I, Muramaki M, Kurahashi T, Takenaka A, Fujisawa M.

Int J Urol. 2009 May;16(5):465-71. doi: 10.1111/j.1442-2042.2009.02262.x.

PMID:
19467119
15.

In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR.

Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, Kristiansen G, Jung K.

BMC Mol Biol. 2007 Jun 8;8:47.

16.

A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.

Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Sano F, Baba M, Kondo K, Nakaigawa N, Kishida T, Nagashima Y, Yamada-Okabe H, Kubota Y.

Int J Cancer. 2008 Sep 1;123(5):1126-32. doi: 10.1002/ijc.23641.

PMID:
18546273
17.

Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alpha.

Figlin RA, de Souza P, McDermott D, Dutcher JP, Berkenblit A, Thiele A, Krygowski M, Strahs A, Feingold J, Boni J, Hudes G.

Cancer. 2009 Aug 15;115(16):3651-60. doi: 10.1002/cncr.24438.

18.

Differential gene expression identifies subgroups of renal cell carcinoma.

Skubitz KM, Zimmermann W, Kammerer R, Pambuccian S, Skubitz AP.

J Lab Clin Med. 2006 May;147(5):250-67. Erratum in: J Lab Clin Med. 2007 Mar;149(3):163. Zimmerman, Wolfgang [corrected to Zimmermann, Wolfgang].

PMID:
16697773
19.

Gene expression profiling of renal medullary carcinoma: potential clinical relevance.

Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM, Vogelzang NJ, Teh BT.

Cancer. 2004 Mar 1;100(5):976-85.

20.

mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.

Christoph F, Hinz S, Kempkensteffen C, Schostak M, Schrader M, Miller K.

J Urol. 2007 Dec;178(6):2655-9. Epub 2007 Oct 22.

PMID:
17945286
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk